Monopar Therapeutics
MNPR----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Monopar Therapeutics(MNPR) predict that the EBIT is -5.225 M (-62.18%), Beat estimate;the EPS is -0.46 (-21.05%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.01B62.18%
-0.01B139.93%
+0.00B77.75%
EPSExceed expectations
-0.4621.05%
-0.81113.16%
+0.350092.11%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf